CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...

Scientists have made a remarkable breakthrough in kidney research. In a paper published in the journal Communications Biology, a team of researchers at Kyoto University led by Ramin Sadeghian present ...

These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification.

CalciMedica (CALC) announced a poster presentation titled, “Store-Operated Calcium-Channel Inhibitor Auxora Improves Kidney Function Following Ischemia-Induced AKI in Rats” at the American Society of ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Chronic kidney disease (CKD) affects more than 700 million people worldwide and is caused by genetic and environmental factors, as well as existing medical conditions. Known genetic risk factors for ...

Kidney failure has a significant impact on public health; about 750,000 Americans and 2 million people around the world are affected every year. People can be treated with dialysis or a transplant, ...

Please provide your email address to receive an email when new articles are posted on . Researchers found limited available study data and inconsistent results. Researchers cite ongoing need to ...

A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in people with lupus nephritis, (LN, lupus-related kidney disease). HCQ (known ...

Learn more about UAB's Xenotransplant program here. “It has been truly extraordinary to see the first-ever preclinical demonstration that appropriately modified pig kidneys can provide normal, ...

Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining ...